Triple
T1633923
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Calico LLC |
E35320
|
entity |
| Predicate | hasLongTermR&DInvestmentAgreementWith |
P9483
|
FINISHED |
| Object | AbbVie |
E184183
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AbbVie | Statement: [Calico LLC, hasLongTermR&DInvestmentAgreementWith, AbbVie]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: AbbVie Context triple: [Calico LLC, hasLongTermR&DInvestmentAgreementWith, AbbVie]
-
A.
AbbVie
chosen
AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
-
B.
Pfizer
Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
-
C.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
-
D.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
E.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasLongTermR&DInvestmentAgreementWith Context triple: [Calico LLC, hasLongTermR&DInvestmentAgreementWith, AbbVie]
-
A.
hasResearchCentersIn
Indicates that an entity maintains or operates research centers located within a specified place or region.
-
B.
hasJointVenture
Indicates that two or more entities are engaged together in a formally established joint business venture or collaborative commercial undertaking.
-
C.
isTechnologicalHubOf
Indicates that a location serves as a central focal point for technological activity, development, or innovation for another specified area or community.
-
D.
isLinkedEconomicallyTo
chosen
Indicates that two entities are connected through economic relationships such as trade, investment, financial flows, or shared market dependencies.
-
E.
sponsoringInstitution
Indicates that an institution provides financial or organizational support to enable or underwrite an activity, project, event, or entity.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a886036bc081909ff5de16dbe5e8ea |
completed | March 4, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69a96083e7308190abbf025fe8e43abb |
completed | March 5, 2026, 10:52 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ad71a61de8819095005c222ec50810 |
completed | March 8, 2026, 12:55 p.m. |
| PD | Predicate disambiguation | batch_69a907cac610819083cafd4396b6d66c |
completed | March 5, 2026, 4:34 a.m. |
Created at: March 4, 2026, 7:28 p.m.